Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Oct 16, 2023; 15(10): 602-613
Published online Oct 16, 2023. doi: 10.4253/wjge.v15.i10.602
Published online Oct 16, 2023. doi: 10.4253/wjge.v15.i10.602
Transoral outlet reduction: Outcomes of endoscopic Roux-en-Y gastric bypass revision in 284 patients at a community practice
Daniel B Maselli, Lauren L Donnangelo, Clinical Research, True You Weight Loss, Atlanta, GA 30342, United States
Vibhu Chittajallu, Department of Gastroenterology and Hepatology, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, United States
Chase Wooley, Areebah Waseem, Daniel Lee, Brian Coan, Christopher E McGowan, Clinical Research, True You Weight Loss, Cary, NC 27513, United States
Michelle Secic, Secic Statistical Consulting, Cleveland, OH 44106, United States
Author contributions: Maselli DB protocol preparation, manuscript preparation and revision; Chittajallu V manuscript preparation; Waseem A protocol preparation, manuscript revision; Lee D data collection, manuscript revision; Secic M statistical analysis; Wooley C protocol preparation, manuscript revision; Donnangelo LL manuscript revision; Coan B manuscript revision; McGowan CE study conceptualization, protocol preparation, manuscript revision.
Institutional review board statement: The study was approved by an Institutional Review Board (WCG IRB, Puyallup, WA).
Informed consent statement: All subjects provided signed consent for their data to be used for scientific publication.
Conflict-of-interest statement: Dr. Daniel B Maselli is a consultant for Apollo Endosurgery, with no proprietary relationship. Dr. Christopher E McGowan previously served as a consultant for Apollo Endosurgery from 2019-2022, with no proprietary relationship. Dr. Vibhu Chittajallu, Dr. Lauren L Donnangelo, Dr. Brian Coan, Mr. Chase Wooley, Ms. Areebah Waseem, Ms. Michelle Secic, and Mr. Daniel Lee have no conflicts of interest or financial ties to disclose.
Data sharing statement: Data can be made available from the corresponding author at drmcgowan@trueyouweightloss.com.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Christopher E McGowan, AGAF, FASGE, MD, Director, Clinical Research, True You Weight Loss, 2001 Weston Pkwy, Cary, NC 27513, United States. drmcgowan@trueyouweightloss.com
Received: July 31, 2023
Peer-review started: July 31, 2023
First decision: August 24, 2023
Revised: August 28, 2023
Accepted: September 11, 2023
Article in press: September 11, 2023
Published online: October 16, 2023
Processing time: 72 Days and 9.3 Hours
Peer-review started: July 31, 2023
First decision: August 24, 2023
Revised: August 28, 2023
Accepted: September 11, 2023
Article in press: September 11, 2023
Published online: October 16, 2023
Processing time: 72 Days and 9.3 Hours
Core Tip
Core Tip: Given the chronic, progressive nature of obesity, weight recurrence after Roux-en-Y gastric bypass (RYGB) is common. Transoral outlet reduction (TORe) is a minimally invasive, same-day, Food and Drug Administration-authorized endoscopic procedure that restricts the gastrojejunal anastomosis to facilitate safe and clinically meaningful weight loss in patients experiencing post-RYGB weight recurrence. To date, nearly all TORe literature has originated in the academic setting. Here, we show that TORe is safe, effective, and technically feasible in the community setting when performed by an experienced bariatric endoscopist and coupled with longitudinal aftercare.